The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

CA16020746

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 0185d46f-b8fb-42ca-8749-6ee669523777

HGVS expressions

NM_000277.3:c.206dup
NC_000012.12:g.102894882dup
CM000674.2:g.102894882dup
NC_000012.11:g.103288660dup
CM000674.1:g.103288660dup
NC_000012.10:g.101812790dup
NG_008690.1:g.27722dup
NG_008690.2:g.68530dup
NM_000277.1:c.206dup
NM_000277.2:c.206dup
NM_001354304.1:c.206dup
ENST00000307000.7:c.191dup
ENST00000546844.1:c.206dup
ENST00000548677.2:n.293dup
ENST00000548928.1:n.128dup
ENST00000549111.5:n.302dup
ENST00000550978.6:n.190dup
ENST00000551337.5:c.206dup
ENST00000551988.5:n.295dup
ENST00000553106.5:c.206dup
ENST00000635500.1:n.174dup

Pathogenic

Met criteria codes 4
PVS1 PP4 PM3 PM2

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.206dupC variant in PAH has been previously reported as a heterozygous variant detected in trans with the known pathogenic c.1066-11G>A variant in a single Caucasian proband with classic PKU; BH4 deficiency was not formally excluded (PMID: 23430918) (PM3, PP4). The variant is a 1bp insertion leading to a nonsense variant which occurs in exon 3 of 13 in the in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (see PMID: 30192042) (PVS1). It is absent from control databases including ethnically matched individuals, including gnomAD/ExAC, 1000 Genomes, and ESP (PM2). In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1, PM2, PM3, PP4.
Met criteria codes
PVS1
The variant is a 1bp insertion leading to a nonsense variant which occurs in exon 3 of 13 in the in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (see PMID: 30192042) (PVS1).
PP4
The c.206dupC variant in PAH has been previously reported as a heterozygous variant detected in trans with the known pathogenic c.1066-11G>A variant in a single Caucasian proband with classic PKU; BH4 deficiency was not formally excluded (PMID: 23430918) (PM3) (PP4).

PM3
The c.206dupC variant in PAH has been previously reported as a heterozygous variant detected in trans with the known pathogenic c.1066-11G>A variant in a single Caucasian proband with classic PKU; BH4 deficiency was not formally excluded (PMID: 23430918) (PM3) (PP4).

PM2
It is absent from control databases including ethnically matched individuals, including gnomAD/ExAC, 1000 Genomes, and ESP (PM2).
Approved on: 2019-04-04
Published on: 2019-08-16
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.